Normalizing tumor blood vessels may improve immunotherapy against brain cancer
Results in mice suggest that combining drugs such as bevacizumab with chimeric antigen receptor–T cell therapy may benefit patients with glioblastoma.
Browse Cancer Center News
Browse Cancer Center news, press releases, videos, patient education articles and more.
426 results
New insights into how blood pressure drug may benefit patients with locally advanced pancreatic cancer
Losartan may augment the benefits of other anti-cancer therapies by reducing tumor invasion and immunosuppression.
Scientists Identify Protein That's Crucial to Tumor Cells' Metabolism and Immune Evasion
By developing a new computational tool, researchers have identified a potential target for anti-cancer therapies that could simultaneously deplete tumors of energy and boost the body’s immune response against them.
Adrenocortical Carcinoma: Erin's Story | Massachusetts General Hospital
A new college grad diagnosed with adrenocortical carcinoma, Erin shares more about working and living with cancer as a young adult. Read her patient story.
Blood Pressure Drug May Prevent Immunotherapy-Induced Brain Swelling in Patients with Glioblastoma
Taking losartan might allow patients with brain cancer to continue receiving immune checkpoint inhibitors without experiencing the medications’ potentially deadly side effect.
Researchers Uncover Racial and Ethnic Disparities in a Widely Used Precision Oncology Data Registry
The team's findings sugggest that these data registries do not reflect the true landscape of cancer patients in the US.
Immunotherapy Combined with Targeted Therapy for Colorectal Cancer Yields Promising Outcomes for Patients
Bench-to-bedside research led from preclinical experiments to a durable response among patients with a difficult-to-treat form of colorectal cancer.
Patients Undergoing Surgery for Cancer Face Higher Risk of Suicide
In U.S. patients who underwent major cancer operations, the incidence of suicide was significantly higher than the general population.
Artificial Intelligence Tool Developed to Predict Risk of Lung Cancer
Using information from a single low-dose chest computed tomography scan, ‘Sybil’ accurately predicted individuals’ lung cancer risk for one to six years in the future, pointing a way toward personalized screening.
Scientists Identify Gene Target to Boost Effectiveness of Cancer Immunotherapy
Silencing the gene may help overcome resistance to cancer immunotherapy.
Showing 1 - 10 of 426 results
Contact the Mass General Cancer Center
An integral part of one of the world’s most distinguished academic medical centers, Mass General Cancer Center is among the leading cancer care providers in the United States.